CVRx, Inc. (CVRX) Gross Margin
- Gross margin · 12 months: Value 86.92%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 86.92% | Gross profit / revenue. Period ending 2026-06-30. $53.18M ÷ $61.19M × 100 ≈ 86.92% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 53.18M USD | Gross Profit |
| Revenue | 61.19M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $53.18M | $61.19M | (m) | 86.92% |
| 2026-03-31 | $50.91M | $59.07M | (m) | 86.18% |
| 2025-12-31 | $48.34M | $56.65M | (m) | 85.33% |
| 2025-09-30 | $47.29M | $55.97M | (m) | 84.49% |
| 2025-06-30 | $45.66M | $54.65M | (m) | 83.54% |
| 2025-03-31 | $44.12M | $52.87M | (m) | 83.44% |
| 2024-12-31 | $42.96M | $51.29M | (m) | 83.75% |
| 2024-09-30 | $39.77M | $47.26M | (m) | 84.16% |
| 2024-06-30 | $37.47M | $44.39M | (m) | 84.40% |
| 2024-03-31 | $35.54M | $42.09M | (m) | 84.45% |
| 2023-12-31 | $33.04M | $39.30M | (m) | 84.08% |
| 2023-09-30 | $29.12M | $35.17M | (m) | 82.81% |
| 2023-06-30 | $25.15M | $30.84M | (m) | 81.54% |
| 2023-03-31 | $20.99M | $26.37M | (m) | 79.61% |
| 2022-12-31 | $17.47M | $22.47M | (m) | 77.75% |
| 2022-09-30 | $14.48M | $18.95M | (m) | 76.39% |
| 2022-06-30 | $12.15M | $16.16M | (m) | 75.19% |
| 2022-03-31 | $10.53M | $14.25M | (m) | 73.88% |
| 2021-12-31 | $9.40M | $13.04M | (m) | 72.08% |
| 2021-09-30 | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) |
| 2020-12-31 | $4.61M | $6.05M | (m) | 76.21% |
| 2020-09-30 | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |